9086:HK:HK-ChinaAMC NASDAQ 100 ETF (USD)

ETF | Others |

Last Closing

USD 5.63

Change

+0.07 (+1.26)%

Market Cap

N/A

Volume

200.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-06 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
2800:HK Tracker Fund of Hong Kong

+0.30 (+1.44%)

USD 140.29B
2833:HK Hang Seng Index Tracking Fund

N/A

USD 30.97B
2828:HK Hang Seng China Enterprises In..

+1.30 (+1.68%)

USD 21.11B
2823:HK iShares FTSE A50 China

+0.13 (+0.99%)

USD 18.01B
2801:HK iShares Core MSCI China ETF

+0.22 (+1.04%)

USD 17.11B
83188:HK ChinaAMC CSI 300 Index ETF

+0.44 (+1.12%)

USD 13.48B
9067:HK iShares Hang Seng TECH ETF

+0.03 (+2.56%)

USD 9.22B
3067:HK iShares Hang Seng TECH ETF

+0.26 (+2.51%)

USD 9.22B
82822:HK CSOP FTSE China A50

+0.12 (+1.05%)

USD 9.11B
9010:HK iShares Core MSCI AC Asia ex J..

+0.04 (+0.50%)

USD 3.03B

ETFs Containing 9086:HK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.99% 66% D+ 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.99% 66% D+ 64% D
Trailing 12 Months  
Capital Gain 21.91% 70% C- 71% C-
Dividend Return 0.87% 5% F 5% F
Total Return 22.78% 70% C- 70% C-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 20.25% 87% B+ 78% C+
Dividend Return 21.13% 87% B+ 77% C+
Total Return 0.88% 30% F 22% F
Risk Return Profile  
Volatility (Standard Deviation) 18.92% 52% F 77% C+
Risk Adjusted Return 111.67% 99% N/A 99% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.